Announced Tue, 19 May · 17:52 IST

Submission of Outcome of Board Meeting held on May, 19 2026 as per Reg.30 of SEBI LODR 2015

Pat Growth 25pctRevenue Growth 20pctEbitda Margin ExpansionRelated Party TransactionsResults View source PDF

SHAILY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+4.3%1-day move
₹2630.00
prior close
₹2403.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+3.4+5.4+13.4+12.4+4.3+2.2+4.6+2.0+1.3+19.4+11.2+5.1+9.2
Up moveDown movePending
AI summary

Shaily Engineering Plastics reported strong FY26 audited results. Standalone revenue grew 23.6% to Rs. 92,120 lakhs while consolidated revenue rose 25.9% to Rs. 99,067 lakhs. Net profit more than doubled on standalone basis to Rs. 16,132 lakhs (up 127% YoY) and consolidated PAT jumped 82.5% to Rs. 16,991 lakhs. The Board recommended a final dividend of Rs. 3 per share (150% on Rs. 2 face value). An enabling resolution was passed for raising up to Rs. 500 crores to fund expansion into healthcare drug delivery devices, consumer electronics, and semiconductor components (including a supply agreement with a Korean firm). Mr. Chi Hung Kam was appointed as COO - Healthcare (KMP) effective May 20, 2026. New internal and cost auditors were appointed for FY27.

Likely market impact

The company delivered exceptional profit growth exceeding 100% on standalone and 82% on consolidated basis, signaling strong execution. The Rs. 500 crore fund raise enables diversification into high-growth adjacent sectors, reducing reliance on traditional precision plastics. Fresh appointment of an experienced healthcare manufacturing leader strengthens execution capability for new verticals.